NDC 70771-1793 – Selexipag
Selexipag 200 ug/1 · Tablet, Film Coated · Oral
Product NDC70771-1793
Product details
- Brand name
- Selexipag
- Generic name
- Selexipag
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- Tablet, Film Coated
- Route
- Oral
- Marketing category
- ANDA · ANDA214302
- Marketed since
- February 14, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Prostacyclin Receptor Agonist
Active ingredients
- Selexipag 200 ug/1
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 70771-1793-6 sample | 60 TABLET, FILM COATED in 1 BOTTLE (70771-1793-6) | Feb 14, 2025 |
| 70771-1793-8 sample | 140 TABLET, FILM COATED in 1 BOTTLE (70771-1793-8) | Feb 14, 2025 |
Other Selexipag products
- 46014-0608 Selexipag .8 mg/1 · Capsule · Excella GmbH & Co. KG
- 46014-0621 Selexipag .2 mg/1 · Capsule · Excella GmbH & Co. KG
- 46014-6280 · Kit · Excella GmbH & Co. KG
- 46014-0602 Selexipag .2 mg/1 · Capsule · Excella GmbH & Co. KG
- 70771-1800 Selexipag 1600 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1799 Selexipag 1400 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1798 Selexipag 1200 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1797 Selexipag 1000 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1796 Selexipag 800 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1795 Selexipag 600 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70771-1794 Selexipag 400 ug/1 · Tablet, Film Coated · Zydus Lifesciences Limited
- 70710-1558 Selexipag 1600 ug/1 · Tablet, Film Coated · Zydus Pharmaceuticals (USA) Inc.